The effects of dual-therapy intensification with insulin or dipeptidylpeptidase-4 inhibitor on cardiovascular events and all-cause mortality in patients with type 2 diabetes: A retrospective cohort study

Jul-17

Cardiovascular Endocrinology Pharmacoepidemiology

AUTHORS : Dr Iskandar Idris, University of Nottingham, Division of Medical Sciences and Graduate Entry Medicine, School of Medicine, Royal Derby Hospital , Uttoxeter Road, Derby DE22 3DT – Email: Iskandar.Idris@nottingham.ac.uk – Profile: https://www.nottingham.ac.uk/medicine/people/iskandar.idris

JOURNAL : Diabetes and Vascular Disease Research

REFERENCE: 14(4):295-303

DOI : 10.1177/1479164116687102

Read more